Agonist-specific recruitment of arrestin isoforms differentially modify delta opioid receptor function

Journal of Neuroscience

Volumn 36, Issue 12, 2016, Pages 3541-3551

  Pradhan, Amynah A ^a,b,c   Perroy, Julie ^d,e   Walwyn, Wendy M ^a,b   Smith, Monique L ^a,b   Vicente Sanchez, Ana ^c   Segura, Laura ^c   Bana, Alia ^a,b   Kieffer, Brigitte L ^f   Evans, Christopher J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^e UNIV MONTPELLIER   (France)

^f DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Arrestin; DRG; GPCR; Pain; Resensitization; Tolerance

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; ARM 390; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; JNJ 20788560; RETINA S ANTIGEN; UNCLASSIFIED DRUG; 4-(ALPHA-(4-ALLYL-2,5-DIMETHYL-1-PIPERAZINYL)-3-METHOXYBENZYL)-N,N-DIETHYLBENZAMIDE; BENZAMIDE DERIVATIVE; ISOPROTEIN; PIPERAZINE DERIVATIVE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS TOLERANCE; DRUG POTENCY; ELECTROPHYSIOLOGY; FEMALE; HUMAN; HUMAN CELL; HYPERALGESIA; INFLAMMATORY PAIN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SPINAL GANGLION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG TOLERANCE; KNOCKOUT MOUSE; METABOLISM; NOCICEPTION; PATHOPHYSIOLOGY;

ANIMALS; ARRESTINS; BENZAMIDES; DRUG TOLERANCE; FEMALE; HYPERALGESIA; MALE; MICE; MICE, KNOCKOUT; PAIN PERCEPTION; PIPERAZINES; PROTEIN ISOFORMS; RECEPTORS, OPIOID, DELTA;

EID: 84961627430     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4124-15.2016     Document Type: Article

References (54)

1. Audet N, Galés C, Archer-Lahlou E, Vallières M, Schiller PW, Bouvier M, Pineyro G (2008) Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins. J Biol Chem 283:15078–15088.
2. Audet N, Charfi I, Mnie-Filali O, Amraei M, Chabot-Doré AJ, Millecamps M, Stone LS, Pineyro G (2012) Differential association of receptorGbetagamma complexes with beta-arrestin2 determines recycling bias and potential for tolerance of delta opioid receptor agonists. J Neurosci 32:4827–4840.
3. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, Caron MG (2000) Muopioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408:720–723.
4. Bohn LM, Lefkowitz RJ, Caron MG (2002) Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knockout mice. J Neurosci 22:10494–10500.
5. Bradbury FA, Zelnik JC, Traynor JR (2009) G protein independent phosphorylation and internalization of the delta-opioid receptor. J Neurochem 109:1526–1535.
6. Byers MA, Calloway PA, Shannon L, Cunningham HD, Smith S, Li F, Fassold BC, Vines CM (2008) Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. J Immunol 181:4723–4732.
7. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55–63.
8. Charfi I, Nagi K, Mnie-Filali O, Thibault D, Balboni G, Schiller PW, Trudeau LE, Pineyro G (2014) Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists. Cell Mol Life Sci 71:1529–1546.
9. Charfi I, Audet N, Bagheri Tudashki H, Pineyro G (2015) Identifying ligand-specific signaling within biased responses: focus on delta opioid receptor (Dop) ligands. Br J Pharmacol 172:435–448.
10. Chiang T, Sansuk K, van Rijn RM (2015) Beta-arrestin 2 dependence of delta opioid receptor agonists is correlated with alcohol intake. Br J Pharmacol. In press
11. Codd EE, Carson JR, Colburn RW, Stone DJ, Van Besien CR, Zhang SP, Wade PR, Gallantine EL, Meert TF, Molino L, Pullan S, Razler CM, Dax SL, Flores CM (2009) JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence. J Pharmacol Exp Ther 329:241–251.
12. Connor M, Bagley EE, Chieng BC, Christie MJ (2015) beta-Arrestin-2 knock-out prevents development of cellular mu-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons. Br J Pharmacol 172:492–500.
13. Coulon V, Audet M, Homburger V, Bockaert J, Fagni L, Bouvier M, Perroy J (2008) Subcellular imaging of dynamic protein interactions by bioluminescence resonance energy transfer. Biophys J 94:1001–1009.
14. Dang VC, Christie MJ (2012) Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons. Br J Pharmacol 165:1704–1716.
15. Doll C, Pöll F, Peuker K, Loktev A, Glück L, Schulz S (2012) Deciphering micro-opioid receptor phosphorylation and dephosphorylation in HEK293 cells. Br J Pharmacol 167:1259–1270.
16. Galandrin S, Oligny-Longpré G, Bouvier M (2007) The evasive nature of drug efficacy: implications for drug discovery. Trends Pharmacol Sci 28: 423–430.
17. Gavériaux-Ruff C, Nozaki C, Nadal X, Hever XC, Weibel R, Matifas A, Reiss D, Filliol D, Nassar MA, Wood JN, Maldonado R, Kieffer BL (2011) Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia. Pain 152:1238–1248.
18. Gendron L, Mittal N, Beaudry H, Walwyn W (2015) Recent advances on the δ opioid receptor: from trafficking to function. Br J Pharmacol 172:403– 419.
19. Groer CE, Schmid CL, Jaeger AM, Bohn LM (2011) Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation. J Biol Chem 286:31731–31741.
20. Hoffmann C, Ziegler N, Reiner S, Krasel C, Lohse MJ (2008) Agonistselective, receptor-specific interaction of human P2Y receptors with betaarrestin-1 and -2. J Biol Chem 283:30933–30941.
21. Hong MH, Xu C, Wang YJ, Ji JL, Tao YM, Xu XJ, Chen J, Xie X, Chi ZQ, Liu JG (2009) Role of Src in ligand-specific regulation of delta-opioid receptor desensitization and internalization. J Neurochem 108:102–114.
22. Just S, Illing S, Trester-Zedlitz M, Lau EK, Kotowski SJ, Miess E, Mann A, Doll C, Trinidad JC, Burlingame AL, von ZastrowM, Schulz S (2013) Differentiation of opioid drug effects by hierarchical multi-site phosphorylation. Mol Pharmacol 83:633–639.
23. Kenakin T (2003) Ligand-selective receptor conformations revisited: the promise and the problem. Trends Pharmacol Sci 24:346–354.
24. Kenakin TP (2012) Biased signalling and allosteric machines: new vistas and challenges for drug discovery. Br J Pharmacol 165:1659–1669.
25. Kouhen OM, Wang G, Solberg J, Erickson LJ, Law PY, Loh HH (2000) Hierarchical phosphorylation of delta-opioid receptor regulates agonistinduced receptor desensitization and internalization. J Biol Chem 275: 36659–36664.
26. Lagerström MC, Schiöth HB (2008) Structural diversity of G proteincoupled receptors and significance for drug discovery. Nat Rev Drug Discov 7:339–357.
27. Lau EK, Trester-Zedlitz M, Trinidad JC, Kotowski SJ, Krutchinsky AN, Burlingame AL, von Zastrow M (2011) Quantitative encoding of the effect of a partial agonist on individual opioid receptors by multisite phosphorylation and threshold detection. Sci Signal 4:ra52.
28. Law PY, Kouhen OM, Solberg J, Wang W, Erickson LJ, Loh HH (2000) Deltorphin II-induced rapid desensitization of delta-opioid receptor requires both phosphorylation and internalization of the receptor. J Biol Chem 275:32057–32065.
29. Lowe JD, Celver JP, Gurevich VV, Chavkin C (2002) mu-Opioid receptors desensitize less rapidly than delta-opioid receptors due to less efficient activation of arrestin. J Biol Chem 277:15729–15735.
30. Luttrell LM (2014) Minireview: More than just a hammer: ligand “bias” and pharmaceutical discovery. Mol Endocrinol 28:281–294.
31. Mittal N, Roberts K, Pal K, Bentolila LA, Fultz E, Minasyan A, Cahill C, Pradhan A, Conner D, DeFea K, Evans C, Walwyn W (2013) Select G-protein-coupled receptors modulate agonist-induced signaling via a ROCK, LIMK, and beta-arrestin 1 pathway. Cell Rep 5:1010–1021.
32. Ong EW, Xue L, Olmstead MC, Cahill CM (2015) Prolonged morphine treatment alters delta opioid receptor post-internalization trafficking. Br J Pharmacol 172:615–629.
33. Perroy J (2010) Subcellular dynamic imaging of protein-protein interactions in live cells by bioluminescence resonance energy transfer. Methods Mol Biol 591:325–333.
34. Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3:639–650.
35. Pradhan AA, Becker JA, Scherrer G, Tryoen-Toth P, Filliol D, Matifas A, Massotte D, Gavériaux-Ruff C, Kieffer BL (2009) In vivo delta opioid receptor internalization controls behavioral effects of agonists. PLoS One 4:e5425.
36. Pradhan AA, Walwyn W, Nozaki C, Filliol D, Erbs E, Matifas A, Evans C, Kieffer BL (2010) Ligand-directed trafficking of the delta-opioid receptor in vivo: two paths toward analgesic tolerance. J Neurosci 30:16459– 16468.
37. Pradhan AA, Befort K, Nozaki C, Gavériaux-Ruff C, Kieffer BL (2011) The delta opioid receptor: an evolving target for the treatment of brain disorders. Trends Pharmacol Sci 32:581–590.
38. Pradhan AA, SmithML, Kieffer BL, Evans CJ (2012) Ligand-directed signalling within the opioid receptor family. Br J Pharmacol 167:960–969.
39. Qiu Y, Loh HH, Law PY (2007) Phosphorylation of the delta-opioid receptor regulates its beta-arrestins selectivity and subsequent receptor internalization and adenylyl cyclase desensitization. J Biol Chem 282:22315–22323.
40. Raehal KM, Bohn LM (2011) The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics. Neuropharmacology 60:58–65.
41. Rajagopal S, Rajagopal K, Lefkowitz RJ (2010) Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat Rev Drug Discov 9:373–386.
42. Reiter E, Ahn S, Shukla AK, Lefkowitz RJ (2012) Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol 52:179–197.
43. Richard-Lalonde M, Nagi K, Audet N, Sleno R, Amraei M, Hogue M, Balboni G, Schiller PW, Bouvier M, Hébert TE, Pineyro G (2013) Conformational dynamics of Kir3.1/Kir3.2 channel activation via delta-opioid receptors. Mol Pharmacol 83:416–428.
44. Scherrer G, Tryoen-Tóth P, Filliol D, Matifas A, Laustriat D, Cao YQ, Basbaum AI, Dierich A, Vonesh JL, Gavériaux-Ruff C, Kieffer BL (2006) Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc Natl Acad Sci USA 103:9691–9696.
45. Shenoy SK (2014) Arrestin interaction with E3 ubiquitin ligases and deubiquitinases: functional and therapeutic implications. Handb Exp Pharmacol 219:187–203.
46. Shenoy SK, Lefkowitz RJ (2011) beta-Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol Sci 32:521–533.
47. Shukla AK, Violin JD, Whalen EJ, Gesty-Palmer D, Shenoy SK, Lefkowitz RJ (2008) Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors. Proc Natl Acad Sci U S A 105:9988–9993.
48. Tudashki HB, Robertson DN, Schiller PW, Pineyro G (2014) Endocytic profiles of delta-opioid receptor ligands determine the duration of rapid but not sustained cAMP responses. Mol Pharmacol 85:148–161.
49. van Rijn RM, Defriel JN, Whistler JL (2013) Pharmacological traits of delta opioid receptors: pitfalls or opportunities? Psychopharmacology 228: 1–18.
50. Walwyn W, Maidment NT, Sanders M, Evans CJ, Kieffer BL, Hales TG (2005) Induction of delta opioid receptor function by up-regulation of membrane receptors in mouse primary afferent neurons. Mol Pharmacol 68:1688–1698.
51. Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, Koch T, Evans CJ, Christie MJ (2013) Regulation of mu-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev 65:223–254.
52. Zhang B, Horvath S (2005) A general framework for weighted gene coexpression network analysis. Stat Appl Genet Mol Biol 4:Article17.
53. Zhang X, Wang F, Chen X, Li J, Xiang B, Zhang YQ, Li BM, Ma L (2005) Beta-arrestin1 and beta-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors. J Neurochem 95:169–178.
54. Zhang X, Wang F, Chen X, Chen Y, Ma L (2008) Post-endocytic fates of delta-opioid receptor are regulated by GRK2-mediated receptor phosphorylation and distinct beta-arrestin isoforms. J Neurochem 106: 781–792.